10 results
Diffuse large B cell lymphoma (DLBCL) - Management and Treatment Algorithm

By Matthew Ho, MD PhD @MatthewHoMD

#Diffuse
Diffuse large B ... and Treatment Algorithm ... MatthewHoMD #Diffuse ... Management #Treatment #Algorithm ... #oncology #hematology
Causes of Diffuse and Localized Lymphadenopathy - Differential Diagnosis Algorithm
 • Reactive (Inflammatory / Infectious)
 •
Causes of Diffuse ... Differential Diagnosis Algorithm ... Metastatic) #Diffuse ... #Causes #Hematology ... #Oncology
Risk factor for VTE in cancer patients

Tumor type 

• Very high risk: gastric, pancreas, brain 

•
Risk factor for ... High risk: lung, hematologic ... renal, bladder #RiskFactors ... #VTE #cancer #oncology
Causes of Diffuse Lymphadenopathy - Differential Diagnosis Algorithm
Reactive:
 - Systemic Inflammatory
     •
Causes of Diffuse ... Differential Diagnosis Algorithm ... Hodgkin's Lymphoma #Diffuse ... #Causes #Hematology ... #Oncology
Causes of Bleeding / Bruising - Differential Diagnosis Algorithm
Thrombocytopenia - Quantitative Defect
 • Decreased Production
 •
Differential Diagnosis Algorithm ... Congenital • Factor ... Deficiency • Factor ... - Acquired • Anticoagulation ... #Causes #Hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... Malignancy #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology ... #Oncology
►
Erythematous Rashes - THE ALGORITHMIC APPROACH

Characterized by diffuse redness of the skin due to
capillary congestion, erythematous
Erythematous Rashes - THE ALGORITHMIC ... Characterized by diffuse ... If these factors ... #Diagnosis #Dermatology ... Erythematous #Rash #Algorithm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... Suggested treatment algorithm ... #Anticoagulation ... #Management #Hematology ... #Oncology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... Transient risk factor ... Thromboembolism #Treatment #Algorithm ... #management #hematology ... #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
• Treatment algorithms ... with no CV risk factors ... Hydroxyurea + anticoagulation ... Thrombocythemia #ET #hematology ... diagnosis #management #hematology